Calprotectin (Stool) Test at Lahore PCR Lab

Calprotectin (Stool) Test at Lahore PCR Lab

The Calprotectin (Stool) Test at Lahore PCR Lab is a highly specialized, non-invasive diagnostic laboratory investigation used to detect and quantify intestinal inflammation. Calprotectin is a 36 kDa calcium- and zinc-binding protein complex composed of S100A8 and S100A9 subunits. It is primarily found within the cytosol of neutrophil granulocytes, representing up to 60% of their total soluble protein content. When inflammatory processes occur in the gastrointestinal tract, neutrophils migrate through the mucosal wall into the intestinal lumen in response to chemotactic stimuli. During this migration, they degranulate and release calprotectin, which is subsequently excreted in the feces. Because calprotectin is remarkably stable in stool samples for up to one week at room temperature and is resistant to enzymatic degradation, it serves as an exceptional and reliable biomarker for gastrointestinal inflammation.

At Lahore PCR Lab, this test is performed using advanced immunological assays, such as Enzyme-Linked Immunosorbent Assay (ELISA) or high-sensitivity rapid immunoassay systems. The primary clinical utility of measuring fecal calprotectin lies in its ability to differentiate between organic inflammatory bowel diseases (IBD), such as Crohn’s disease and Ulcerative Colitis, and functional gastrointestinal disorders, most notably Irritable Bowel Syndrome (IBS). Because IBS does not involve structural mucosal damage or inflammatory cell infiltration, calprotectin levels remain normal. Conversely, active IBD causes a significant rise in fecal calprotectin. This distinction is crucial for clinical decision-making, helping physicians avoid unnecessary invasive procedures like colonoscopies for patients with functional disorders while identifying those who require urgent endoscopic evaluation.

The anatomical focus of this test spans the entire gastrointestinal tract, with a primary emphasis on the small and large intestines. By measuring the concentration of this protein in a stool specimen, gastroenterologists and general physicians can assess mucosal health, monitor disease activity, evaluate response to therapeutic interventions, and predict clinical relapses. The diagnostic value of fecal calprotectin is widely recognized globally, offering a cost-effective, rapid, and patient-friendly alternative to invasive diagnostic pathways, making it an indispensable tool in modern gastroenterology.

Clinical Procedure: What to Expect

Patient Preparation

Appropriate patient preparation is vital to ensure the accuracy and reliability of the Calprotectin (Stool) Test at Lahore PCR Lab. Patients are advised to adhere to the following guidelines prior to sample collection:

• Medication Review: Patients must inform their referring physician about all medications they are currently taking. Non-Steroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen, naproxen, and high-dose aspirin, can cause mild mucosal irritation and transient inflammation in the gut, leading to false-positive results. It is generally recommended to discontinue NSAIDs for at least two weeks before the test, under medical supervision.
• Proton Pump Inhibitors (PPIs): Long-term use of PPIs can alter gut microflora and lead to mild elevations in fecal calprotectin. Patients should discuss with their doctor whether to temporarily pause these medications.
• No Dietary Restrictions: There are no specific dietary restrictions required for this test. Patients can continue their regular diet unless otherwise instructed by their physician.
• Avoid Contamination: The stool sample must not be contaminated with urine, toilet water, menstrual blood, or cleaning chemicals, as these can degrade the calprotectin protein or interfere with the assay.
• Collection Timing: It is ideal to collect the first bowel movement of the day, as it provides a concentrated sample, though samples collected at other times are also acceptable.

During the Procedure

The collection of the stool sample is performed by the patient in the comfort of their home, ensuring privacy and convenience. The clinical procedure involves the following steps:

• Sample Collection Kit: The patient is provided with a sterile, leak-proof stool collection container from Lahore PCR Lab. This container often features an integrated spoon or spatula attached to the cap to facilitate clean handling.
• Collection Method: The patient should pass stool into a clean, dry receptacle (such as a plastic wrap placed over the toilet bowl or a clean bedpan) rather than directly into the toilet water. Using the provided spatula, a small portion of the stool (approximately the size of a walnut, or 5 to 10 mL if liquid) should be transferred into the sterile container.
• Labeling and Transport: The container must be tightly sealed, clearly labeled with the patient’s full name, registration number, date, and time of collection. The sample should be transported to Lahore PCR Lab as soon as possible. If a delay of more than a few hours is expected, the sample should be refrigerated (between 2°C and 8°C) but never frozen.
• Laboratory Processing: Upon arrival at Lahore PCR Lab, the specimen undergoes extraction, where a precise weight of the stool is mixed with an extraction buffer. The supernatant is then analyzed using quantitative ELISA or automated immunoassay technology to measure the exact concentration of calprotectin in micrograms per gram (µg/g) of stool.
• Safety and Comfort: Because the collection is non-invasive, there is absolutely no physical pain, discomfort, or risk of complications associated with this procedure.

When is a Calprotectin (Stool) Test Performed?

Distinguishing Inflammatory Bowel Disease (IBD) from Irritable Bowel Syndrome (IBS)

Physicians frequently order a fecal calprotectin test when a patient presents with chronic gastrointestinal symptoms that could point to either IBD or IBS. Because the clinical presentations of these conditions overlap significantly—featuring abdominal pain, bloating, and altered bowel habits—the test serves as a crucial triage tool. A low calprotectin level strongly suggests a functional disorder like IBS, sparing the patient from undergoing invasive colonoscopies and bowel preparations. Conversely, an elevated level alerts the clinician to active mucosal inflammation, indicating the need for diagnostic endoscopy and biopsy to confirm IBD.

Monitoring IBD Activity and Treatment Response

For patients already diagnosed with Crohn’s disease or Ulcerative Colitis, the Calprotectin (Stool) Test is performed periodically to monitor the inflammatory status of the gut. Clinical symptoms do not always correlate perfectly with mucosal healing. By measuring calprotectin levels, gastroenterologists can objectively assess whether a treatment regimen (such as biologics, immunosuppressants, or corticosteroids) is successfully reducing mucosal inflammation. A downward trend toward normal levels indicates therapeutic success and mucosal healing, while persistently high levels suggest the need for treatment optimization or a change in medication.

Investigating Chronic Diarrhea and Persistent Abdominal Pain

When patients present with unexplained chronic diarrhea lasting more than four weeks, accompanied by persistent abdominal pain, a calprotectin test is indicated. These symptoms can stem from various etiologies, including chronic infections, malabsorption syndromes, or autoimmune enteropathies. The test helps clinicians determine if the underlying cause is inflammatory. If calprotectin is elevated, it directs the diagnostic pathway toward inflammatory conditions, whereas normal levels prompt investigations into non-inflammatory causes of diarrhea, such as bile acid malabsorption, lactose intolerance, or celiac disease.

Detecting Early Disease Relapse in Crohn’s or Ulcerative Colitis

In patients with IBD who are currently in clinical remission, fecal calprotectin is an excellent predictive marker for impending disease relapse. Subclinical inflammation often precedes the return of physical symptoms by several weeks or months. Regular monitoring of calprotectin levels allows clinicians to detect a silent rise in intestinal inflammation. Identifying this early signal enables proactive clinical intervention, such as adjusting medication dosages, which can prevent a full-blown symptomatic flare-up and reduce the risk of hospitalization.

Evaluating Pediatric Gastrointestinal Symptoms

In pediatric medicine, avoiding invasive diagnostic procedures is a high priority. Children presenting with recurrent abdominal pain, chronic diarrhea, poor growth, or unexplained weight loss pose a diagnostic challenge. The Calprotectin (Stool) Test is highly valuable in pediatric gastroenterology as a non-invasive screening tool. It helps pediatricians differentiate between functional abdominal pain of childhood and pediatric inflammatory bowel disease, ensuring that invasive endoscopies are reserved only for children with a high probability of organic disease.

What Does a Calprotectin (Stool) Test Detect?

The Calprotectin (Stool) Test is highly sensitive to neutrophil activity in the gastrointestinal tract and can detect a wide range of inflammatory, infectious, and structural conditions, including:

• Active Crohn’s disease (ileal, colonic, or ileocolonic involvement)
• Active Ulcerative Colitis (proctitis, left-sided colitis, or pancolitis)
• Bacterial gastroenteritis (e.g., Salmonella, Campylobacter, Shigella, or Clostridioides difficile infections)
• Viral enteritis causing mucosal damage
• Parasitic intestinal infections (e.g., Amebiasis, Giardiasis with mucosal irritation)
• Non-Steroidal Anti-inflammatory Drug (NSAID)-induced enteropathy
• Diverticulitis (inflammation of diverticula in the colon)
• Colorectal carcinoma (due to tumor-associated inflammation and mucosal ulceration)
• Large adenomatous polyps with surface ulceration
• Active Celiac Disease with significant mucosal inflammation
• Microscopic colitis (including collagenous and lymphocytic subtypes)
• Food protein-induced enterocolitis syndrome (FPIES)
• Necrotizing enterocolitis (primarily in neonatal clinical settings)
• Gastrointestinal Graft-Versus-Host Disease (GVHD) in transplant patients
• Eosinophilic gastroenteritis
• Peptic ulcer disease with active bleeding or surrounding mucosal inflammation
• Radiation proctitis or enteritis
• Ischemic colitis (compromised blood flow leading to mucosal necrosis and inflammation)
• Systemic vasculitis involving the mesenteric vasculature
• Juvenile polyposis syndrome with inflamed polyps

Turnaround Time and Report Access at Lahore PCR Lab

Lahore PCR Lab is committed to providing rapid, accurate, and reliable diagnostic reports to facilitate timely clinical decisions. The turnaround time for the Calprotectin (Stool) Test is typically 24 to 48 hours from the time the specimen is received at the laboratory. Because the test requires precise extraction and highly calibrated immunoassay runs, our specialized pathology team ensures that every sample undergoes rigorous quality control checks before results are authorized.

Patients and referring physicians can access reports conveniently through multiple digital channels. Once the report is finalized, an automated SMS notification containing a direct download link is sent to the patient’s registered mobile number. Reports can also be accessed and downloaded securely via the official Lahore PCR Lab online patient portal. For patients who prefer physical copies, printed reports can be collected directly from the main laboratory or any of our official collection centers across Lahore.

Calprotectin (Stool) Test Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Fecal Calprotectin Concentration	< 50 µg/g (Indicates no significant intestinal inflammation)	50 – 120 µg/g (Borderline/Mild elevation); > 120 µg/g (Significant active inflammation)
Neutrophil Migration Activity	Absent or minimal neutrophil infiltration into the gut lumen	High rate of neutrophil migration across the mucosal barrier
Mucosal Barrier Integrity	Intact, healthy gastrointestinal mucosa	Compromised mucosal barrier, ulcerations, or inflammatory lesions
Medication Interference	No recent use of NSAIDs or high-dose PPIs	Recent NSAID use causing drug-induced enteropathy and false-positive elevation
Specimen Consistency	Formed or semi-formed stool specimen	Loose, watery, or bloody stool associated with active colitis or enteritis
Infectious Pathogens	Negative for pathogenic bacteria, viruses, or parasites	Presence of enteric pathogens triggering acute mucosal inflammation
Clinical Correlation	Points toward functional disorders like Irritable Bowel Syndrome (IBS)	Points toward organic disorders like Inflammatory Bowel Disease (IBD) or neoplasia

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Calprotectin (Stool) Test?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, clinical biochemists, and laboratory technologists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, privacy, and convenience throughout the sample submission and reporting process.
• Quality Diagnostic Services: Lahore PCR Lab adheres to strict internal and external quality control protocols to ensure the highest level of testing accuracy.
• Professional Reporting: Our diagnostic reports are comprehensive, clear, and structured to provide clinicians with actionable insights.
• Modern Diagnostic Approach: We utilize state-of-the-art automated immunoassay and ELISA platforms for precise biomarker quantification.
• Comfortable Environment: Our collection centers in Lahore are designed to provide a clean, hygienic, and welcoming environment for patients.
• Convenient Location: Located centrally in Lahore, our main lab and collection points are easily accessible from all parts of the city.
• Commitment to Accurate Diagnosis: We understand the clinical importance of distinguishing IBD from IBS, and we ensure every test is processed with meticulous care.